Alice Chen specializes in health economics and labor economics. Professor Chen has expertise in a range of issues involving healthcare and pharmaceutical firms, including pharmaceutical competition and innovation, healthcare labor markets, and provider payment models. She has served as a consulting expert on damages issues in a life sciences matter, and has offered written and deposition testimony in healthcare matters related to health insurance plan design. She has also provided healthcare consulting services to pharmaceutical companies, and has experience analyzing drug clinical trial data.
Professor Chen’s research has focused on improving the efficiency of healthcare markets, biologics and biosimilars innovation and competition, and the drivers and impacts of healthcare provider behavior. Her recent research analyzes the impact of Medicare policies on provider treatment decisions and healthcare outcomes. Professor Chen has presented her work before regulators at the Federal Trade Commission and the Congressional Budget Office.
Professor Chen has published articles in leading economics, health policy, and medical journals, including the American Economic Journal: Economic Policy, Health Affairs, JAMA Internal Medicine, and the Journal of Health Economics. Her research has also been cited in major media outlets, including Bloomberg, CBS News, Forbes, the New York Times, and the Washington Post.
At USC Price, Professor Chen teaches undergraduate- and graduate-level courses in health economics and health finance. The USC Health Administration Graduate Program has recognized her as Outstanding Faculty of the Year.
The Inflation Reduction Act Could Have Unintended Consequences
The Inflation Reduction Act’s Effects on the Life Sciences Industry
American Conference Institute: 14th Summit on Biosimilars & Innovator Biologics